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HEALTH RELATED QUALITY OF LIFE IN A NATIONAL SAMPLE OF CAREGIVERS – 
A MULTILEVEL ANALYSIS  
Patel HK, Sansgiry SS, Mehta P 
University of Houston, Houston, TX, USA  
OBJECTIVES: Individual characteristics along with contextual factors could 
impact caregiver’s health related quality of life (HRQoL), eventually affecting care 
recipient’s disease management. This study attempted to identify individual 
(age, gender, race, education and employment status) and county-level (median 
household income) predictors of caregiver’s HRQoL. METHODS: Data from 2009-
2010 Behavioral Risk Factor Surveillance System was used. Only caregivers, 
identified as adults (≥18 years) indicating provision of regular care/assistance to 
a friend/family member with a health problem during the past month were 
included in the analyses. Caregiver’s overall HRQoL was measured as the sum of 
number of physically and mentally unhealthy days and days with activity 
limitation. Two-level (individuals nested in county) model was tested using proc 
mixed in SAS 9.3. The model assessed impact of caregiver’s age, gender, race, 
education and employment status along with contextual effects of age and 
gender on their HRQoL. Median household income for each county was 
considered as the level-2 predictor. RESULTS: A total of 29,945 caregivers in 283 
counties were analyzed. The intra-class correlation co-efficient of the null model 
was 0.0063 indicating a very low proportion of variability in observed score 
attributable to variability across counties. Consequently, median household 
income (county level) although significant, had a very small impact (ß=-0.00002; 
p<0.0001). All individual level factors such as increasing age (ß=-0.016; p<0.0001), 
being female (ß=-0.305; p=0.0081), white (ß=-0.922; p<0.0001), having higher 
education (ß=-1.289; p<0.0001) and being employed (ß=-3.468; p<0.0001) had a 
significant negative impact on caregivers’ HRQoL. Random effect of age 
(ß=0.0004; p=0.0262) was significant whereas impact of gender (ß=0.4885; 
p=0.0543) did not vary significantly across counties. CONCLUSIONS: Most of the 
impact on caregiver’s HRQoL can be explained by individual level factors. County 
specific median household income practically did not have an impact. Employed 
caregivers, those with increasing age, employed, whites and females had lower 
HRQoL score.  
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A RETROSPECTIVE, OBSERVATIONAL STUDY OF PATIENT OUTCOMES FOR 
CRITICALLY ILL PATIENTS RECEIVING PARENTERAL NUTRITION  
Magee G1, Zaloga G2, Sanon M2 
1Premier, Inc, Charlotte, NC, USA, 2Baxter Healthcare, Deerfield, IL, USA  
OBJECTIVES: To evaluate the clinical and economic outcomes for critically ill 
patients receiving parenteral nutrition (PN) administered via premixed multi-
chamber bag (MCB) or compounded solutions (COM). METHODS: A retrospective 
database analysis of critically ill patients (ICU stay >3 days) receiving PN & 
discharged between January 1, 2010 and June 30, 2011 using Premier Hospital 
Database. Patients were identified as receiving MCB or COM based on product 
description codes. Method of pharmacy compounding (i.e., automated or 
manual) was not identified. Comorbidities and clinical outcomes were identified 
using ICD-9 diagnosis codes. All costs reported were for inpatient services only. 
MCB and COM patients were matched on key patient and hospital characteristics 
using a propensity score methodology. Multivariate regression models for cost 
and length of stay used log transformation techniques. RESULTS: A total of 
42,631 patients met the inclusion criteria (MCB=5,679; COM=36,952) and the final 
matched population included 3,559 patients from each cohort. Baseline patient 
and hospital characteristics were well matched between the two groups. Results 
of multivariate models adjusting for patient characteristics showed no difference 
in risk of infection and 30-day readmission between groups (OR= 0.966, p = 0.56 
and OR=0.915, p=0.25), respectively. Small difference observed in length of stay 
(MCB=9.40 vs. COM=9.65, p = 0.014). MCB patients incurred about 9.1% less in 
total costs (MCB=$37,790 vs. COM=$41,569, p < 0.001). CONCLUSIONS: Overall 
patients receiving MCB or compounded PN experienced similar clinical outcomes 
but those receiving MCB had lower total costs. Any interpretation of the study 
findings are subject to several limitations most notably the lack of information 
about compounding method and determinants of prescribing MCB or 
compounding PN. Additional adequately powered studies that include explicit 
identification of method for compounding and a well matched cohort on 
baseline disease status are needed.  
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PREVALENCE AND PREDICTORS OF PRESCRIBING POTENTIALLY 
INAPPROPRIATE ANTICHOLINERGIC MEDICATIONS IN THE ELDERLY  
Medhekar RA1, Kachru N2, Aparasu RR1 
1University of Houston, Houston, TX, USA, 2University of Houston, College of Pharmacy, 
Houston, TX, USA  
OBJECTIVES: Medications with anticholinergic properties are frequently 
associated with severe adverse events in the elderly, and therefore highly 
anticholinergic agents are considered potentially inappropriate in this 
population. The objectives of this study were to determine the prevalence and 
predictors of prescribing potentially inappropriate anticholinergic medications 
among elderly patients in ambulatory settings. METHODS: This study involved 
analyses of visits by elderly patients (>65 years) in office-based settings from 
2009 public use data files of the National Ambulatory Medical Care Survey 
(NAMCS). The revised 2012 American Geriatrics Society (AGS) Beers criteria were 
used to identify potentially inappropriate anticholinergic medications. 
Descriptive analysis was conducted using sampling weights to determine the 
prevalence of visits involving inappropriate anticholinergic medications 
irrespective of diagnosis. Multiple logistic regression within the framework of 
Andersen Behavioral Model (ABM) was used to determine the predictors of 
potentially inappropriate anticholinergic medications in the elderly. RESULTS: A 
total of 279.5 million visits (26.93% of all clinic visits) to physician offices in 2009 
involved elderly patients. Approximately 13.33 million visits (4.77% of all clinic 
visits by the elderly patients) involved at least one potentially inappropriate 
anticholinergic medication. The most frequently used anticholinergics were 
antihistamines followed by antispasmodics and skeletal muscle relaxants. 
Factors positively associated with inappropriate anticholinergic prescribing were 
female gender, major reason for visit, number of medications prescribed and 
specialty. Factors negatively associated with inappropriate anticholinergic 
prescribing were age, total number of chronic conditions and region. 
CONCLUSIONS: Nearly one in twenty visits by the elderly involved prescribing of 
potentially inappropriate anticholinergic medications. These prescribing 
patterns raise quality of care concerns owing to the significant adverse events 
associated with their use in the vulnerable population.  
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USING A HA-CMC BARRIER TO AVOID PELVIC OR ABDOMINAL ADHESION: 
COST-BENEFIT ADVANTAGES IN A PRIVATE HEALTH CARE SETTING  
Ferreira CN1, Follador W2, Paloni EDMP3, Santana CFSD4, Bonachela F5 
1ORIZON - Companhia Brasileira de Gestão de Serviços, Sao Paulo, Brazil, 2Sanofi, São Paulo , 
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OBJECTIVES: To demonstrate net costs reduction obtained by the prophylactic 
use of a HA-CMC* pellicle during some kinds of abdominal and pelvic surgeries. 
METHODS: A cost-benefit economic model was developed to compare options of 
adopting or not the use of HA-CMC barriers during abdominal / pelvic surgeries 
as a prophylactic way to avoid adhesions in these sites and one of major 
consequences, the small bowel obstruction. Data of costs of care for the 
treatment of small bowel obstruction were obtained from a 16-million lives 
databank of private health care providers. Data on probabilities were obtained 
from scientific literature for gathering risks of adhesion and other outcomes, as 
so the efficacy of the bio-absorbable pellicle to avoid adhesion. RESULTS: In the 
population and period studied, it were identified 9002 patients submitted to 
pelvic and abdominal procedures, which showed average costs of US$ 2,607.90 
and US$ 5,394.67, respectively, for each case of intervention. Into this same 
population, the cost of interventions to treat adhesions has shown an average 
cost of US$ 3,918.29. It was assumed that the cost of using HA-CMC (1-3 unities) 
varies from US$ 262 – 786, and the efficacy of this kind of prophylaxis varies from 
54% to 78% and 47% to 61% for gynaecologic and abdominal procedures, 
respectively. It was demonstrated that the net savings would be 6% to 17% for 
gynaecologic procedures and 3% to 7% for abdominal surgeries. CONCLUSIONS: 
Considering the frequency and average costs of each re-operation needed to 
treat the small bowel obstructions due abdominal and pelvic adhesions, as the 
cost of prophylaxis using biodegradable barriers, it was clearly demonstrated 
that this prophylaxis results in savings from the perspective of the third part 
payers. [*HA-CMC: hyaluronic acid – carboxymethylcellulose (Seprafilm®, Sanofi)]  
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MINIMALLY INVASIVE COSMETIC PROCEDURES: PATIENT MOTIVATION AND 
SATISFACTION  
DiEdwardo CA1, O'Brien JA2 
1Lahey Clinic Medical Center, Lexington, MA, USA, 2Independent Consultant, Lincoln, MA, USA  
OBJECTIVES: Cosmetic surgery has decreased in the recent economic downturn; 
however, some minimally-invasive cosmetic procedures saw an increase in the 
same period. Studies show that work environment behavior, treatment and 
earnings are influenced by an employee’s physical appearance. This study aims 
to assess the motivations of patients for obtaining these procedures, types of 
procedures obtained and satisfaction with outcome. METHODS: Self-
administered questionnaire was given to 39 established patients at an academic 
plastic surgery clinic. Data variables included age, sex, gender, marital status, 
overall health, employment and economic status, procedure type, motivating 
factors and patient satisfaction. Personal identifiers were not collected. 
Procedure costs were an out-of-pocket expense for all participants. RESULTS: Of 
39 participants [90% >40 yrs, 64% employed, 59% annual household income 
>$100K], 37 reported reasons for obtaining procedures.”To appear refreshed” 
(70%) and “to look younger” (65%) were most commonly reported motivations. Of 
those employed (n=25), 12% reported a job-related reason. Among the 34 
reporting procedure type, 83 procedures [per patient (n): range: 1-7; mean: 2.4] 
were obtained: injectable fillers (n=29), botulinum toxin type A injection (n=25), 
micro-dermabrasion (n=13), non-ablative laser rejuvenation (n=10), chemical peel 
(n=3) and thermacool (n=3). Of 31 reporting satisfaction data, 84% stated that the 
procedure(s) met expectations and 79% would repeat the same, or have another, 
non-surgical procedure. While 51% reported a negative impact on household 
income from the economic downturn, only 3 (10%) patients would not repeat the 
procedures due to cost. CONCLUSIONS: This study provides insight into patients’ 
choices of minimally invasive non-surgical cosmetic procedures, motivations for 
obtaining them and satisfaction with outcome. In this limited sample, 
employment-related and economic factors did not dominate; however, this 
result may differ in a broader sample. Understanding motivating factors and 
patient satisfaction can improve approach to patient consultation, and practice 
management.  
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